Cytomegalovirus CmvHhv5 Igg Kimutatas Jelentéseelisa Modszerrel Vircell

Lab Reagents

Cytomegalovirus Antibody Laboratories manufactures the cytomegalovirus cmv/hhv5 igg kimutatas jelentéseelisa modszerrel vircell reagents distributed by Genprice. The Cytomegalovirus Cmv/Hhv5 Igg Kimutatas Jelentéseelisa Modszerrel Vircell reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact cytomegalovirus Antibody. Other Cytomegalovirus products are available in stock. Specificity: Cytomegalovirus Category: Cmv/Hhv5 Group: Igg Kimutatas

Igg Kimutatas information

Virus Cytomegalovirus (CMV) Protein
abx670257-1ml 1 ml
EUR 493.2

Cytomegalovirus Antibody / CMV / PP65
V2332-100UG 100 ug
EUR 499
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65
V2332-20UG 20 ug
EUR 219
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65
V2332SAF-100UG 100 ug
EUR 499
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65
V2333-100UG 100 ug
EUR 499
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Cytomegalovirus Antibody / CMV / PP65
V2333-20UG 20 ug
EUR 219
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Cytomegalovirus Antibody / CMV / PP65
V2333SAF-100UG 100 ug
EUR 499
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Cytomegalovirus (CMV) Chimeric 1 Protein
abx061513-1mg 1 mg
EUR 1796.4

Cytomegalovirus gH (CMV gH) Antibody
abx415688-01mg 0.1 mg
EUR 777.6

Cytomegalovirus (CMV) IgM ELISA Kit
K4151-100 each
EUR 646.8

Human Cytomegalovirus IgG / IgM, Toxoplasma IgG / IgM, Rubella IgG Rapid Test Kit
abx092078-20tests 20 tests
EUR 410.4

CMV (Cytomegalovirus Antibody IgM) ELISA test
29 96T/Box Ask for price
Description: ELISA based test for quantitative detection of CMV (Cytomegalovirus Antibody IgM)

Virus Cytomegalovirus Antigen (CMV-Ag) Protein
abx670278-1mg 1 mg
EUR 1045.2

Cytomegalovirus Early Antigen (CMV-EA) Antibody
abx411287-02mg 0.2 mg
EUR 678

CMV control lentivirus (Hygro)
CMV-Null-Hygro 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the hygromycin selection under RSV promoter.

CMV control lentivirus (Zeo)
CMV-Null-Zeo 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the Zeocin selection under RSV promoter.

CMV Control lentiviral particles (Bsd)
CMV-Null-Bsd 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the blasticidin marker under RSV promoter.